Branded

CVS Health touts low drug price growth for PBM clients

The company said that last year, drug price growth clocked in at 0.2% for its CVS Caremark clients, even as manufacturer price inflation neared 10%.
CVS Health expands patient naloxone education efforts

The efforts are in-line with the Surgeon General’s Advisory on Naloxone an Opioid Overdoses that the nation’s top doctor, Jerome Adams, released Thursday.
Dr. Reddy’s names Teva vet COO

Erez Israeli took over the role of COO from Abhijit Mukherjee, who had been with the company for 15 years.
Mylan’s triple-combo HIV treatment launches

The once-daily Symfi is indicated as a complete HIV treatment regimen in adults and children weighing at least 40 kg.
Sun Pharma's Ilumya gets FDA approval

The biologic drug is indicated to treat moderate-to-severe plaque psoriasis who are candidates for systemic or photo therapy.
Azar: Drug pricing efforts coming soon

Health and Human Services secretary Alex Azar teased forthcoming initiatives while highlighting the record number of generic approvals last year.
Research debunks Tamiflu-suicide link in children

Clinical studies examining the association between the use of Tamiflu and neuropsychiatric side effects in children, including suicide, have so far been inconclusive
CVS Health shares efforts to address drug costs at AHIP conference

The company’s efforts include a new program that offers drug cost transparency for patients, pharmacists and prescribers.

Q&A: Alok Sonig highlights Dr. Reddy’s efforts to improve access to medicine